Nav: Home

RUDN biochemists described a new mechanism for autoimmunity suppression

September 07, 2018

The ability of a human body to resist pathogenic factors is under control of immune cells, the most important of which are lymphocytes. The first subtype called effector lymphocytes, contacts with viruses and bacteria or cells affected by them and kill the patogenes. After the pathogens are destroyed, such lymphocytes should die as well, otherwise they may turn into autoimmune cells causing autoimmune diseases and allergies by attacking other normal cells of the same body. Another subtype, regulatory T-cells, prevents the development of such aggressive autoimmune cells. Scientists are aware that regulatory T-cells are able to suppress effector lymphocytes upon direct contact by activating special receptors on their membranes. Regulatory T-cells contact with the surface of the target cell and activate self-destruction processes.

"The mechanisms of autoimmunity suppression by regulatory T-cells are widely studied. However, it is not always obvious how they manage to react over distance. In our work we've described a completely new distant (contact independent) mechanism based on "accelerated ageing" of effector lymphocytes," says Dmitry Zhdanov, assistant professor of the department biochemistry named after Academician T.T. Berezov at RUDN Institute of Medicine.

Each cell in our body has a limited number of divisions. The regulatory mechanism for this limitation is quite simple and determined by nature itself. Upon each new division the end regions of chromosomes called telomeres are reduced. After a certain number of divisions, the telomeres become critically short and the cells become aged (they are still alive but unable to divide). Afterwards these cells die. Unlike the majority of other cells, immune cells have the enzyme called telomerase that synthesized telomeres. This allows lymphocytes to have more division instances and quickly reproduce when a body is hit by an infection.

RUDN biochemists co-cultivated effector autoimmune lymphocytes and regulatory T-cells separated with a special membrane in one culture flask for a long time. The cells were unable to contact directly, but could distantly exchange soluble substances. It turned out that regulatory T-cells were able to inhibit the activity of telomerase in effector lymphocytes. Long-term cultivation of autoimmune lymphocytes with inactive telomerase caused their telomere loss and cell death. The effect was observed not only in the artificial conditions of cell co-cultivation, but also in living mice.

"Based on the obtained results we've discribed a new, previously unknown mechanism of autoimmunity regulation based on physiological ageing of immune cells and the activation of their self-destruction processes. Obviously, this process is a fundamental one to support cell functions and determine the fate of the cells. The understanding of this mechanism may be useful for the development of treatments for autoimmune diseases and prevention of implant rejection," concludes Dmitry Zhdanov.
-end-


RUDN University

Related Immune Cells Articles:

Nutrient deficiency in tumor cells attracts cells that suppress the immune system
A study led by IDIBELL researchers and published this week in the American journal PNAS shows that, by depriving tumor cells of glucose, they release a large number of signaling molecules.
Experience matters for immune cells
The discovery that immune T cells have a spectrum of responsiveness could shed light on how our immune system responds to infections and cancer, and what goes wrong in immune diseases.
Immune cells against Alzheimer's?
German researchers have developed a novel, experimental approach against Alzheimer's.
Arming the body's immune cells
Researchers at UC have discovered a previously unknown mechanism that could explain the reason behind decreased immune function in cancer patients and could be a new therapeutic target for immunotherapy for those with head and neck cancers.
Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.
How an immune system regulator shifts the balance of immune cells
Researchers have provided new insight on the role of cyclic AMP (cAMP) in regulating the immune response.
How the immune system becomes blind to cancer cells
Researchers have described the activation of a key protein used by tumor cells to stop the body's immune response.
What protects killer immune cells from harming themselves?
White blood cells, which release a toxic potion of proteins to kill cancerous and virus-infected cells, are protected from any harm by the physical properties of their cell envelopes, find scientists from UCL and the Peter MacCallum Cancer Centre in Melbourne.
How self-reactive immune cells are allowed to develop
A research team at Lund University in Sweden has found the mechanism that controls the growth of B1-cells in mice.
Identification of new populations of immune cells in the lungs
In an article published in Nature Communications, the Immunophysiology Laboratory of the GIGA Institute, headed by Prof.
More Immune Cells News and Immune Cells Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.